Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Ovid Therapeutics (OVID) Debt to Equity (2020)

Ovid Therapeutics (OVID) has disclosed Debt to Equity for 1 consecutive years, with $0.06 as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Debt to Equity changed N/A year-over-year to $0.06, compared with a TTM value of $0.06 through Dec 2020, changed N/A, and an annual FY2020 reading of $0.06, changed N/A over the prior year.
  • Debt to Equity was $0.06 for Q4 2020 at Ovid Therapeutics, up from $0.0 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.06 in Q4 2020 and bottomed at $0.0 in Q3 2020.